Since virtually nothing is known about p-Tau in either PD or DLB, we sought to undertake a comprehensive analyses identifying the number of epitopes of Tau that are hyperphosphorylated in different brain regions of these diseases, while also investigating the activation of various Tau kinases. This evidence concerns the gene MAPT and Parkinson disease.